Impact of PCSK9 and acid ceramidase on obese hypothyroidism female patients
| dc.contributor.author | Mohammed Rajab Abed AL-Joboury | |
| dc.contributor.author | Nagham Qasim Kadhim | |
| dc.contributor.author | Saif M. Hasan | |
| dc.date.accessioned | 2025-12-29T08:05:59Z | |
| dc.date.issued | 2024-08-23 | |
| dc.description.abstract | Proprotein Convertase subtilisin Kexin type 9 (PCSK9) is a serine protease composed of 692 residues. Acid ceramidase is an enzyme that hydrolyzed ceramide to sphingosine and fatty acids | |
| dc.format | application/pdf | |
| dc.identifier.uri | https://peerianjournal.com/index.php/tpj/article/view/922 | |
| dc.identifier.uri | https://asianeducationindex.com/handle/123456789/14587 | |
| dc.language.iso | eng | |
| dc.publisher | Peerian Journals Publishing | |
| dc.relation | https://peerianjournal.com/index.php/tpj/article/view/922/761 | |
| dc.rights | https://creativecommons.org/licenses/by/4.0 | |
| dc.source | The Peerian Journal; Vol. 33 (2024): TPJ; 65-71 | |
| dc.source | 2788-0303 | |
| dc.subject | Hypothyroidism | |
| dc.subject | obesity | |
| dc.subject | PCSK9 and acid ceramidase | |
| dc.title | Impact of PCSK9 and acid ceramidase on obese hypothyroidism female patients | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | Peer-reviewed Article |
item.page.files
item.page.filesection.original.bundle
pagination.showing.detail
loading.default
- item.page.filesection.name
- al-joboury_2024_impact_of_pcsk9_and_acid_ceramidase_on_o.pdf
- item.page.filesection.size
- 293.63 KB
- item.page.filesection.format
- Adobe Portable Document Format